News
$CHRS - Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
Sep 23, 2026 · ThinkSabio Blog
$CHRS - Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
23-SEP-2026 09:30 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
